Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

The focus of its treatments includes patients with Parkinson's disease, Rett Syndrome, Amyotrophic Lateral Sclerosis, schizoprenia, and neuropathic pain.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Number of employees : 23 persons.
Sales per Businesses
20142015Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Drugs1.58100%1.9279.1% +21.76%
Sales per Regions
20142015Delta
CHF (in Million)%CHF (in Million)%
Global1.58100%1.9279.1% +21.76%
Managers
NameAgeSinceTitle
Stefan Weber512005Chief Executive Officer, Director & IR Contact
Ulrich Köstlin, PhD642013Non-Executive Chairman
Roberto Galli-2002Vice President-Finance
Ravi Anand, MD592005Chief Medical Officer
Patrick J. Langlois, PhD712008Independent Non-Executive Director
Robert Leslie Holland MD, PhD612013Independent Non-Executive Director
Bo Jesper Hansen MD, PhD582013Independent Non-Executive Director
Joseph Donald deBethizy, PhD652014Independent Non-Executive Director
Luca Benatti, PhD552014Independent Non-Executive Director
Marco Caremi592002Executive Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 15,773,168 11,496,528 72.9% 0 0.0% 72.9%
Shareholders
NameEquities%
Investor AB 1,772,817 11.2%
Gefim SpA 1,311,957 8.32%
Aviva Plc 1,307,550 8.29%
JPMorgan Asset Management (UK) Ltd. 258,613 1.64%
UBS AG (Investment Management) 231,094 1.47%
Polar Capital LLP 150,334 0.95%
Union Investment Privatfonds GmbH 149,140 0.95%
Aviva Investors Global Services Ltd. 121,616 0.77%
Credit Suisse AG 103,655 0.66%
AXA Investment Managers (Paris) SA 60,000 0.38%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
NEWRON PHARMACEUTICALS..-27.93%281
AMGEN, INC.-11.29%108 084
GILEAD SCIENCES, INC.-28.43%95 331
CELGENE CORPORATION-2.67%90 358
REGENERON PHARMACEUTIC..-31.88%39 005
ACTELION LTD45.20%21 671
VERTEX PHARMACEUTICALS..-40.00%18 739
GENMAB A/S30.03%10 399
TESARO INC166.74%7 453
EXELIXIS, INC.207.98%5 108
HUALAN BIOLOGICAL ENGI..--.--%4 742
TONGHUA DONGBAO PHARMA..-83.36%4 737
NEUROCRINE BIOSCIENCES..-23.58%3 788
ULTRAGENYX PHARMACEUTI..-33.54%3 139
CHINA BIOLOGIC PRODUCT..-19.21%3 123
BEIJING SL PHARMACEUTI..--.--%2 925
GW PHARMACEUTICALS PLC80.73%2 835
PEPTIDREAM INC40.33%2 748
BIOCON LTD78.01%2 700
BLUEBIRD BIO INC12.35%2 691
KITE PHARMA INC-17.62%2 674
Sector Bio Therapeutic Drugs
Newron Pharmaceuticals SpA : Connections
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2016 People , Fundamentals and Ownership